In this edition, ultra-processed grains linked to elevated risk for IBD, CTA use for GI bleeds increase and more. Read the full coverage here: Ultra-processed grains linked to elevated risk for IBD, especially ulcerative colitis 'Double whammy:' CTA use for GI bleeds rise, but diagnostic yield drops 'Another layer of benefit': GLP-1s linked to lower risk for peptic ulcer disease 'Simplified care models' needed for chronic HBV care to meet 2030 global elimination goals 'Stay vigilant': Routine exposure to AI may reduce ADR in standard colonoscopy References: Budzyń K, et al. Lancet Gastroenterol Hepatol. 2025;doi:10.1016/S2468-1253 (25) 00133-5. Narula N, et al. Am J Gastro. 2025;doi:10.14309/ajg.0000000000003700. Prasad S, et al. JAMA Netw Open. 2025;doi:10.1001/jamanetworkopen.2025.29746. Seika P, et al. Clin Gastroenterol Hepatol. 2025;doi:10.1016/j.cgh.2025.08.015. Stockdale AJ, et al. Lancet Gastroenterol Hepatol. 2025;doi:10.1016/S2468-1253(25)00163-3.

Ver todos los episodios